Table 4.
Recovery and matrix effect of LVFX in rat liver tissues, urine, and feces (n = 5).
| Biosamples | Spiked concentration (ng/mL) | Extraction recovery | Matrix effect | ||
|---|---|---|---|---|---|
| Mean ± SD | RSD (%) | Mean ± SD | RSD (%) | ||
| LVFX in liver tissue | 10.02 | 90.84 ± 9.21 | 10.14 | 93.09 ± 6.72 | 7.22 |
| 100.20 | 89.11 ± 6.24 | 7.00 | 103.03 ± 2.50 | 2.43 | |
| 5010.00 | 89.60 ± 4.69 | 5.24 | 97.64 ± 6.08 | 6.23 | |
|
| |||||
| LVFX in urine | 10.02 | 94.07 ± 7.88 | 8.38 | 93.02 ± 4.09 | 4.39 |
| 200.40 | 91.84 ± 10.21 | 11.11 | 89.06 ± 6.53 | 7.33 | |
| 4008.00 | 93.12 ± 5.71 | 6.14 | 103.18 ± 9.78 | 9.48 | |
|
| |||||
| LVFX in feces | 10.02 | 93.94 ± 8.39 | 8.93 | 89.96 ± 4.86 | 5.41 |
| 20.04 | 91.36 ± 7.60 | 8.31 | 93.00 ± 5.36 | 5.76 | |
| 200.40 | 101.13 ± 7.14 | 7.06 | 92.67 ± 9.76 | 10.53 | |